New Delhi : Bharat Biotech’s Covid-19 vaccine Covaxin secured approval from the Drugs Controller General of India
(DCGI) on Tuesday for use on children above 2 years of age in a major boost to the country’s fight against the pandemic.
Covaxin will be the first Covid-19 vaccine in the country to be administered to those below 18 years of age.
The Subject Expert Committee (SEC) for Covid-19 drugs under Central Drugs Control Standard Organisation (CDSCO) earlier recommended the Covaxin in two-dose regimen to be given at a gap of 28 days as primer and booster shots.
More Stories
Puri BRICS Disaster Risk Reduction Meeting Opens; Odisha CM Calls for Stronger Global Cooperation
India–U.S. Agricultural Cooperation Gains New Momentum Through Key Dialogue Led by IFFCO Chairman Dileep Sanghani
Bear enters Primary Health Center premises, Video goes on viral